ReviewAesthetic surgery journal2026
From Bench to Bedside: Clinical Implications of a 4-Micron Surface-Modulated Immune Response in the Era of Breast Tissue Preservation.
Review in Aesthetic surgery journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tissue Preservation in Primary Breast Augmentation: From Founding Concepts to Early Evidence.Aesthetic surgery journal · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast implant surface topography plays a critical role in modulating host immune responses and long-term clinical outcomes. Although traditional classifications dichotomize implant surfaces as smooth or textured, emerging evidence demonstrates that specific architectural parameters differentially regulate macrophage polarization, T cell recruitment, and fibrotic capsule formation. This narrative review synthesizes preclinical, translational, and clinical evidence evaluating immune modulation associated with a specific 4 µm surface architecture and discusses its implications for capsular contracture, chronic inflammation, biointegration, and the corresponding consequences for conservative surgical techniques. Across animal models, capsule histology, proteomic analyses, and gene expression studies, this specific 4 µm surface consistently demonstrates reduced proinflammatory macrophage infiltration, enhanced FoxP3 + regulatory T cell recruitment, and decreased profibrotic signaling with thinner yet elastic structured capsules compared with both conventional smooth and high roughness surfaces, favoring immune regulation rather than chronic inflammation. Capsule behavior is governed not by thickness alone but by structural organization, elasticity, and immune profile. Clinically, these findings translate into low rates of capsular contracture without increased risks of implant instability, when appropriately managed. Collectively, these converging data support a broader conceptual framework in which foreign body response is a biologically modifiable process. Modulating this response through surface topography enables the development of an optimized implant-tissue interface that promotes physiologic healing, minimizes adverse outcomes, and supports natural breast biomechanics. Within this framework, coupling this specific architecture with breast tissue-preserving techniques, this biologic profile provides a foundation for stable, low-inflammatory implant integration without reliance on complex maneuvers, additional structural support or excessive fibrotic adhesion. Level of Evidence: 5 (Therapeutic) For image description, please refer to the figure legend and surrounding text.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.